Sanofi
A global integrated healthcare leader discovers, develops and distributes therapeutic solutions.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
* | N/A | €1.5b | Post IPO Debt |
| Total Funding | 000k | ||
| EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 5 % | 16 % | 2 % | (5 %) | - | 7 % | 7 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 27 % | 30 % | 33 % | 30 % | 30 % | 31 % | 31 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 16 % | 15 % | 12 % | 13 % | 19 % | 18 % | 18 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 15 % | 15 % | 14 % | 17 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Sanofi is a global healthcare company dedicated to providing innovative treatments and life-saving vaccines to millions of people worldwide. Operating in the pharmaceutical and biotechnology sectors, Sanofi focuses on research and development (R&D) to address unmet medical needs in areas such as immunology, oncology, rare diseases, and vaccines. The company serves a diverse range of clients, including patients, healthcare professionals, and governments, by offering a broad portfolio of prescription medicines, over-the-counter products, and vaccines.
Sanofi's business model revolves around extensive R&D efforts, strategic partnerships, and a robust pipeline of new products. The company invests heavily in scientific innovation to develop breakthrough therapies and improve existing treatments. Revenue is generated through the sale of pharmaceutical products and vaccines, as well as through collaborations and licensing agreements with other healthcare entities.
Sanofi operates in a highly competitive market, with a strong presence in both developed and emerging markets. The company leverages its global reach and expertise to navigate regulatory environments and deliver its products to those in need. By focusing on patient-centric solutions and maintaining a commitment to quality and safety, Sanofi aims to improve health outcomes and enhance the quality of life for people around the world.
Keywords: healthcare, pharmaceuticals, vaccines, R&D, immunology, oncology, rare diseases, biotechnology, global reach, patient-centric.
Tech stack
